chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very red hands; chemical taste in mouth within 5 minutes of shot; Burning tongue and lower front gums within 10 minutes of shot; Burning tongue and lower front gums within 10 minutes of shot; Throat started to burn and swell within 20 minutes of shot; Throat started to burn and swell within 20 minutes of shot; Blood Pressure shot up to 190 over 90 and don't have high blood pressure; Heart rate increased from resting of 65 to 80's and 90's; This is a spontaneous report from a contactable consumer. A 71-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in right arm on 24Mar2021 15:15 (Batch/Lot Number: ER2613) as single dose for covid-19 immunisation in hospital. Medical history included asthma, allergies, intolerance to some narcotics and Opioids. Not pregnant at the time of vaccination. No patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Historical vaccination included BNT162B2 on 3Mar2021 02:45 PM, lot number:EN6205,in right arm, dose 1 for covid-19 immunisation. Concomitant medication(s) included Cortisone shot left shoulder, Rhinocort, Flovent. The patient experienced very red hands and chemical taste in mouth within 5 minutes of shot, burning tongue and lower front gums within 10 minutes of shot, throat started to burn and swell within 20 minutes of shot, blood pressure shot up to 190 over 90 and don't have high blood pressure, heart rate increased from resting of 65 to 80's and 90's on 24Mar2021 15:15 with outcome of not recovered.  Therapeutic measures were taken as 3 tablets of predniSONE 20 mg, Allerest. Events are non serious.  Follow-up attempts have been completed and no further information is expected
01/19/22 presents to Birth Center Triage for "elevated home BP" "36w4d". PMHx of "Anemia, Anxiety, Diabetes mellitus"
5 days after the patient's first shot a mark appeared on her back that is similar to a bruise.   That mark/bruise began to fade and  one week later another mark/bruise appeared on her throat. That mark/bruise began to fade and one week later another mark/bruise appeared on her arm.  The mark/bruise does not hurt like a typical bruise and there was no injury to the skin.  The original mark/bruise is still lightly visible. The patient's physician was concerned about platelets so she checked her blood on 12/29/21. The results came back normal.  Her doctor is referring us to a hematologist.  The patient has not been sick or acted any different. She still has an appetite and has plenty of energy. We are not saying the vaccine caused this issue. However, this issue only occurred after her Covid vaccination.
On 01/20/2023 at 11:40am a 37 year old female, requested a Moderna Covid Bivalent Booster. She reported to RN that she got hives 2 days after receiving her previous Moderna Covid Booster lot#070H21A on 12/21/2021. Her hives went away the next day and she did not seek medical attention. No medical conditions. She did not report any reaction with the previous 2 primary series doses of Moderna Covid Vaccines. At 11:47 texted Dr. for a medical consult. "Good morning. We have a 37 yo female requesting Moderna Bivalent booster. She reports getting hives appearing 2 days following her last booster on 12/23/2021. She states she had no SOB, anaphylaxis or swelling. The hives went away the next day. She reports having hives previously in her teens possibly from seafood or cold weather. She is currently taking Benadryl. Please advise." At 11:48 am Dr. replied via text "No problem, she can receive booster. At 11:53 am, Client received a Moderna Covid Bivalent Booster lot#046H22A in the left deltoid by RN. Client was educated to seek medical attention if a severe allergic reaction were to occur. Client left with a steady gait after a 30 minute observation period.
pain in left arm (similar to getting a flu shot; like someone punched my arm), full body ache, chills, migraine; lasted the entire day
1. Acute deep vein thrombosis (DVT) of tibial vein of left lower extremity (CMS/HCC)   No history of any DVT
Information has been received from a health professional via a line listing concerning an 82 year old male patient who on 04-DEC-2002 was vaccinated with a dose of PNEUMOVAX 23.  On 02-OCT-2007, the patient was vaccinated with another dose of PNEUMOVAX 23.  The patient subsequently experienced injection site swelling.  The reporter felt that injection site swelling was related to vaccination with PNEUMOVAX 23.  It was unknown if the patient recovered from injection site swelling.  No further information is available.
lightheaded/dizzy; was on my hands & knees to get to the car; I was weak; Vomiting; Headache; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (lightheaded/dizzy), GAIT DISTURBANCE (was on my hands & knees to get to the car), ASTHENIA (I was weak), VOMITING (Vomiting) and HEADACHE (Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (I had numbness & tingling in fingers, arms, jaw, lost taste & smell, & had sinus pressure. Treatment received: Over the counter cold medicines.) on 22-Jun-2020, Numbness in fingers (fingers, arms, jaw Treatment received: Over the counter cold medicines.) on 22-Jun-2020, Tingling (in fingers, arms, jaw Treatment received: Over the counter cold medicines.) on 22-Jun-2020, Taste loss (Treatment received: Over the counter cold medicines.) on 22-Jun-2020, Smell loss (Treatment received: Over the counter cold medicines.) on 22-Jun-2020 and Sinus pressure (Treatment received: Over the counter cold medicines.) on 22-Jun-2020.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced DIZZINESS (lightheaded/dizzy), GAIT DISTURBANCE (was on my hands & knees to get to the car), ASTHENIA (I was weak), VOMITING (Vomiting) and HEADACHE (Headache). On 16-Jan-2021, DIZZINESS (lightheaded/dizzy), GAIT DISTURBANCE (was on my hands & knees to get to the car), ASTHENIA (I was weak), VOMITING (Vomiting) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jun-2020, SARS-CoV-2 test: positive (Positive) Positive for Covid-19..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Over the counter cold medicines were provided as a treatment for symptoms.
Headache, Sedation, fatigue and pain at the injection site. Narrative:  Other Relevant History:
his voice was very nasally; myalgia involving his spine; Severe arm pain (localized to the injection site); diffuse myalgia involving his spine; Stuffy nose; severe headache; Impossible to sleep; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included intervertebral disc disorder (had underlying discs issue, which have not been causing problems lately).   On 6th August 2019, the patient received the 1st dose of Shingrix. On 6th August 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, myalgia, nasal stuffiness, headache, difficulty sleeping and pain in spine. On 7th August 2019, the patient experienced voice alteration. On an unknown date, the outcome of the injection site pain, myalgia, nasal stuffiness and headache were not recovered/not resolved and the outcome of the difficulty sleeping, voice alteration and pain in spine were unknown.   It was unknown if the reporter considered the injection site pain, myalgia, nasal stuffiness, headache, difficulty sleeping, voice alteration and pain in spine to be related to Shingrix.  Additional details were provided as follows: The physician who used to work as a Head of Safety calling and stated that the patient who received Shingrix and several hours later the patient developed a severe systemic reaction. Severe arm pain at injection site and diffuse myalgia involving his spine, severe headaches and stuffy nose. The caller could tell something was wrong when speaking with the patient at the time of reporting because his voice was very nasally. The symptoms made it impossible for him to sleep.  The reporter consented to follow up. Details regarding the vaccine given or responsible physician was unknown. This case linked with US2019143886, reported by same reporter.
injection site soreness; This spontaneous report was received from a 45-year-old male patient consumer and refers to himself. The patient concomitantly received several unspecified medication and had allergies to bee stings and adhesive bandages. No information regarding pertinent medical history was provided.   On an unspecified date in September 2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscular (dose, site of administration, lot # and expiration date were not provided) for prophylaxis. The patient reported that he has missed his second scheduled vaccination by over a month and on unspecified date in September 2019, he experienced injection site soreness.The patient sought medical attention and visited to physician. There was no treatment given for the event. On an unspecified date in 2019 (reported as couple days after receiving the vaccine), the patient recovered.   The relatedness between the event and the therapy with pembrolizumab (KEYTRUDA) was not provided.
a day and half to 2 days following the shot, I developed a cyst like nodule on my left collarbone (same side of the body shot was administered). I assume it was/is a severely swollen lymph node. In addition to this i began to experience headaches, tiredness, body pain and diarrhea for the next few days. At this point all side effects have gone away with the exception of the swollen lymph node, which has reduced in size but is still fairly prominent and painful (5 days after the first dose was administered)
She first got a fever for more than 24 hours and then a rash five days later on her chest and stomach.
after receiving vaccine, approximately 15 minutes later, patient had a panic episode, pt was short of breath, but able to breath with no signs of anaphylaxis. EMS was called by daughter and pharmacist were notified. Patient was able to walk to stretcher and left in ambulance.
Initial report received from a non-healthcare professional (patient relative) on 03 November 2014. A male patient, whose medical history and concomitant medications was not reported, had received a dose of Flu shot (batch number, dose, dose in series, route of administration and site of administration was not reported) on 01 January 2014 at 10.15 am. On 01 January 2014, approximately 12 hr. after vaccination, the patient experienced fever 101.5 degree C. Laboratory investigations was not reported. The patient was treated with ADVIL on an unspecified date. On 02 January 2014 the patient was recovered from the event. Documents held by sender: none.
Fever, runny nose, inconsolable crying, flu-like symptoms. 11/18/2008 MR received from PCP.  12 mon WCC on 11/28/2006 with normal PE, growth and development. in for OV 12/28/06 with c/o coughing, not sleeping well. Assess: URI, cold. Vax given . Seen for sick visit 3/26/07-sinusitis. 18 mon WCC 4/05/07, PE WNL.  Seen 7/6/08 for sick visit - Hand, Foot Mouth Disease. Sppech eval for grunting, no words.  9/25/07 Refered for Austism screen for lack of speech, lack in interaction with other children, lack of eye contact. Dx: of Autism by specialist/Developmental Delay (speech and language).
14MAR94 11AM p/shot pain @ vax site & generalized body ache then fever, chills x nausea x 2 days; 15MAR93 redness around inject site which extended to involve entire lt elbow & ecchymosis ax & lt breast w/ 1 x 2 cm tender node lt axilla;
Information has been received from a pharmacist concerning a 2 month old male who "about 1 week ago" (approximately 22-AUG-2008) was vaccinated with his first oral dose of ROTATEQ vaccine live (human-bovine). Concomitant therapy included tetanus toxoid and hepatitis B virus vaccine (unspecified). The pharmacist reported that her son vomited about 75% of his first dose of ROTATEQ vaccine live (human-bovine). Later that day, he had a fever of 100.7 degrees F and was given TYLENOL. Subsequently, the patient recovered from vomited about 75% of ROTATEQ vaccine live (human-bovine) and fever of 100.7 degrees F on an unknown date. No medical attention was sought. No product quality complaint. Additional information has been requested.
Developed swelling redness and pain at vaccine site at right deltoid/biceps where Pneumovax was administered. Worse with touching or movement of the arm.
Patient is 15 years and 10 months old and was administered a booster dose of Pfizer vaccine.  Not currently approved or indicated in this age.    Description of reported administration error:  "Patient came into office today and her mother wanted patient to get a COVID pfizer booster. Dr approved of the vaccine booster. After the vaccine was given, we realized she is only 15 and 10 months, and not yet 16, which is the approved age for the pfizer booster. Mother was called and a message was left for her to call us back."
redness, fever, aches 10/16/08-records received for DOS 9/28-10/2/08-DC DX: Cellulitis to right arm. Presented to ED with C/O right arm pain, redness at injection site that began 3-4 days ago. C/O chills, sweats and increased redness. Day of vaccines C/O sinus infection, diagnosed with sinusitis.
Patient had severe skin reaction to RabAvert vaccine. Regimen stopped at this time due to full body ruby red rash with swollen tongue covered with white spots, tongue too sore to eat, skin sensitive to touch and sore throat. 5th dose of PEP regimen held for now. Follow up on 7/25/05: We completed the PEP Series for Rabies, albeit a couple of weeks late for the fifth dose with a dose of HDCV on an inpatient basis, EPI, and Benadryl ready in case of an allergic reactin. No reaction occurred. No subsequent problems from the fith dose to date. Information from medical records states dehydration. msv
Information has been received from a physician concerning a female employee who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed local pain and swelling. Unspecified medical attention was sought and no treatment was required. No product quality complaint was involved. The physician may not be contacted. No further information is expected.
1-20-10 Pt. c/o severe headache. Went home from work. Lost vision in left eye. 1-21-10 pt c/o moderate - severe body aches and vomiting > 3x. 1-22-10 pt. returned to work. Vision returned completely. Pt had hx of rare heart disease which she failed to reveal prior to immunization during verbal screening. Pt answered "no" to B.2 on consent form. Pt has experienced migraines and loss of vision previously unrelated to immunization. The pt's doctor said he did not think pt response was related to H1N1 vaccine.
120mm red, pruritic erythematous patch surrounding injection site; no lymphadenopathy, no systemic symptoms/signs; started within 2 days after vaccination; treated with diphenhydramine, fluocinonide ointment
Vaccine administered 3/3/10. Pt seen on 3/5/10 with H/o swelling, redness, pain at upper arm that spread on 3/4/10 & was getting worse. L upper arm erythematous, indurated, swollen, very tender & hot to touch on 3/5/10. Txd with p.o. KEFLEX 7 day course.
Area where pt received vaccine was red, hot, blotchy and itchy. Pt was put on oral antibiotics.
On 3.10.21 at approximately 10:45 am,  vaccinator RN came to Lead RN, notified about Janssen vial containing bubbles. Lead RN notified supervisor about the vial and waited for confirmation to continue use. When confirmation was given the two hours allowed at room temperature had passed and the Janssen with lot # 1805020 and expiration date of 5/25/21 dose had been drawn was administered to client, at vaccination site at 12:49 pm by vaccinator RN. Client was observed for 15 minutes and denied any adverse reactions. However, supervisor approved for Janssen to be given to client. Upon reviewing the guidance received from Johnson and Johnson by supervisor afterward that the dose given had to be given to the client again. County will call client to schedule client for another Janssen vaccine.
Rash around mouth 4/11/17, green, mucous stools started on 4/9/17, positive for blood on 4/12/17. Has continued with symptoms even with mom switching to a non-dairy and soy diet.
Rash covering both arms, has continued to spread and worsen after 2nd shot, starting to spread to other parts of body.
Vision started to get blurry; Double vision at long distances; Troubles trying to walk; Eyelids are drooping down and are almost closed all the way; This is a spontaneous report from a non-contactable consumer or other non hcp (patient).   A male patient of an unspecified age received BNT162b2 (CONMINTARY, Solution for injection, Lot No: was not reported), via an unspecified route of administration on Mar2021 as 1st dose, single for covid-19 immunisation.The patient medical history and concomitant medications were not reported.The patient experienced vision started to get blurry, double vision at long distances, troubles trying to walk, eyelids are drooping down and are almost closed all the way on an unspecified date. Patient wants to know if this is a side effect of the vaccine. The outcome of the events for vision started to get blurry, double vision at long distances was not recovered, troubles trying to walk, eyelids are drooping down and are almost closed all the way was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
My 16 year old son received Moderna by mistake; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Jul-2021 and was forwarded to Moderna on 01-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 16 year old son received Moderna by mistake) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 16 year old son received Moderna by mistake). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 16 year old son received Moderna by mistake) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Pt noticed side effects of redness with swelling and pain, itching, warmth and bruising at site of injection.
basically flu-like symptons: woke up with splitting headache-lasted approx 22hrs: tylenol 1000mg 2pm,  rizitriptan ODT 10mg  10pm ,  tylenol 1000mg 4:50am injection arm very very sore-hurt to move-lasted all day & night; woke up Sunday am not near as sore & could move. fever 2.2 degrees over normal ( normal 97.2 after injection 99.4) all morning; went down after took tylenol @ 2pm Sat, came back  then went away in evening body very achey  all day after/Sat.-back to normal next day/Sun
Patient was anxious about getting a shot before but she was ok during administration, and after waiting 15 minutes. Store staff reported that she was lying on the ground at parking lot. Main symptoms were muscle weakness and dizziness so she couldn't stand up. EMT came in but pt refused to take ambulance. Per patient, she will go to hospital with her husband.
covid test date=11Jan2022/covid test result=Positive; covid test date=11Jan2022/covid test result=Positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Nov2021 18:30 (Lot number: 3302680) at the age of 29 years as dose 2, single and administered in arm left, administration date 26Oct2021 18:45 (Lot number: 320308D) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: Feb2020 (unspecified if ongoing), notes: if covid prior vaccination: Yes, Already had COVID-19 in Feb2020, with antibodies in T-cells, prior to vaccination. The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Jan2022, outcome "unknown" and all described as "covid test date=11Jan2022/covid test result=Positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (11Jan2022) positive, notes: Nasal Swab.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store.Prior to vaccination, the patient was diagnosed with COVID-19.Device Date : 14Jan2022  Follow-up attempts are completed. No further information is expected.
First vaccine Johnson & Johnson, March 2021 Booster Moderna Covid-19 vaccine Very swollen and painful lymph node in left armpit, same side as injection.
Patient said that she started to feel sick and somewhat dizzy approximately 5 minutes after receiving the vaccination.  She vomited; after about 5-10 minutes later the vomiting/dizziness subsided.